ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
5
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,886
similar
All similar
Record
: found
Abstract
: not found
Book
: not found
Biologics License Application (BLA) for lisocabtagene maraleucel
Author(s):
Publication date:
2021
Read this book at
Bookmark
There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
ScienceOpen Research
Data availability:
Comments
Comment on this book
Sign in to comment
Similar content
3,886
Updated safety and long-term clinical outcomes in TRANSCEND NHL 001, pivotal trial of lisocabtagene maraleucel (JCAR017) in R / R aggressive NHL abstract S800 R / R aggressive B-NHL associated with high unmet need and poor outcomes
Authors:
JS Abramson
,
LI Gordon
,
ML Palomba
TRANSCEND CLL 004: minimal residual disease (MRD) negative responses after lisocabtagene maraleucel (Liso-Cel; JCAR017), a CD19-directed CAR T cell product, in patients (pts) with relapsed/refractory chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL)
Authors:
T. Siddiqi
,
KA Dorritie
,
JD Soumerai
Lisocabtagene maraleucel (Liso-Cel) manufacturing process control and robustness across CD19+ hematological malignancies
Authors:
J Teoh
,
TG Johnstone
,
B Christin
See all similar
Cited by
1
Nanoparticles for Enhanced Adoptive T Cell Therapies and Future Perspectives for CNS Tumors
Authors:
Preethi Balakrishnan
,
Elizabeth Sweeney
See all cited by